vs
Church & Dwight（CHD）とEncompass Health Corp（EHC）の財務データ比較。上の社名をクリックして会社を切り替えられます
Church & Dwightの直近四半期売上が大きい（$1.6B vs $1.5B、Encompass Health Corpの約1.1倍）。Encompass Health Corpの純利益率が高く（9.5% vs 8.7%、差は0.7%）。Encompass Health Corpの前年同期比売上増加率が高い（9.9% vs 3.9%）。過去8四半期でEncompass Health Corpの売上複合成長率が高い（8.3% vs 4.6%）
チャーチ・アンド・ドワイトはアメリカの消費財企業で、1847年に創業し本社はニュージャージー州ユーイングにある。パーソナルケア、家庭用品、特殊製品を主力事業とし、Arm & Hammer、Trojanなどの有名ブランドを傘下に持ち、2022年の売上高は54億米ドルに達した。
エンコンパスヘルスコーポレーション（旧Amcare、HealthSouth）は米国アラバマ州バーミンガムに本社を置く米国最大の入院リハビリサービス事業者で、39州とプエルトリコに173の入院リハビリ病院を展開し、脳卒中や神経疾患、心肺疾患、脳損傷から回復中の患者に専門的な治療とケアを提供している。
CHD vs EHC — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $1.6B | $1.5B |
| 純利益 | $143.5M | $146.1M |
| 粗利率 | 45.8% | — |
| 営業利益率 | 16.2% | 16.7% |
| 純利益率 | 8.7% | 9.5% |
| 売上前年比 | 3.9% | 9.9% |
| 純利益前年比 | -24.2% | 20.8% |
| EPS（希薄化後） | $0.60 | $1.43 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $1.6B | $1.5B | ||
| Q3 25 | $1.6B | $1.5B | ||
| Q2 25 | $1.5B | $1.5B | ||
| Q1 25 | $1.5B | $1.5B | ||
| Q4 24 | $1.6B | $1.4B | ||
| Q3 24 | $1.5B | $1.4B | ||
| Q2 24 | $1.5B | $1.3B | ||
| Q1 24 | $1.5B | $1.3B |
| Q4 25 | $143.5M | $146.1M | ||
| Q3 25 | $182.2M | $126.5M | ||
| Q2 25 | $191.0M | $142.1M | ||
| Q1 25 | $220.1M | $151.5M | ||
| Q4 24 | $189.2M | $120.9M | ||
| Q3 24 | $-75.1M | $108.2M | ||
| Q2 24 | $243.5M | $114.1M | ||
| Q1 24 | $227.7M | $112.5M |
| Q4 25 | 45.8% | — | ||
| Q3 25 | 45.1% | — | ||
| Q2 25 | 43.0% | — | ||
| Q1 25 | 45.0% | — | ||
| Q4 24 | 44.7% | — | ||
| Q3 24 | 45.2% | — | ||
| Q2 24 | 47.1% | — | ||
| Q1 24 | 45.7% | — |
| Q4 25 | 16.2% | 16.7% | ||
| Q3 25 | 16.1% | 14.9% | ||
| Q2 25 | 17.4% | 16.2% | ||
| Q1 25 | 20.1% | 16.4% | ||
| Q4 24 | 16.2% | 14.3% | ||
| Q3 24 | -6.1% | 13.6% | ||
| Q2 24 | 22.3% | 14.3% | ||
| Q1 24 | 20.3% | 13.6% |
| Q4 25 | 8.7% | 9.5% | ||
| Q3 25 | 11.5% | 8.6% | ||
| Q2 25 | 12.7% | 9.7% | ||
| Q1 25 | 15.0% | 10.4% | ||
| Q4 24 | 12.0% | 8.6% | ||
| Q3 24 | -5.0% | 8.0% | ||
| Q2 24 | 16.1% | 8.8% | ||
| Q1 24 | 15.1% | 8.5% |
| Q4 25 | $0.60 | $1.43 | ||
| Q3 25 | $0.75 | $1.24 | ||
| Q2 25 | $0.78 | $1.39 | ||
| Q1 25 | $0.89 | $1.48 | ||
| Q4 24 | $0.76 | $1.18 | ||
| Q3 24 | $-0.31 | $1.06 | ||
| Q2 24 | $0.99 | $1.12 | ||
| Q1 24 | $0.93 | $1.10 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $409.0M | $72.2M |
| 総負債低いほど良い | $2.2B | $2.4B |
| 株主資本純資産 | $4.0B | $2.4B |
| 総資産 | $8.9B | $7.1B |
| 負債/資本比率低いほどレバレッジが低い | 0.55× | 1.00× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $409.0M | $72.2M | ||
| Q3 25 | $305.3M | $48.7M | ||
| Q2 25 | $923.2M | $99.1M | ||
| Q1 25 | $1.1B | $95.8M | ||
| Q4 24 | $964.1M | $85.4M | ||
| Q3 24 | $752.1M | $147.8M | ||
| Q2 24 | $491.7M | $154.4M | ||
| Q1 24 | $349.7M | $134.4M |
| Q4 25 | $2.2B | $2.4B | ||
| Q3 25 | $2.2B | $2.4B | ||
| Q2 25 | $2.2B | $2.3B | ||
| Q1 25 | $2.2B | $2.3B | ||
| Q4 24 | $2.2B | $2.4B | ||
| Q3 24 | $2.2B | $2.3B | ||
| Q2 24 | $2.2B | $2.7B | ||
| Q1 24 | $2.2B | $2.7B |
| Q4 25 | $4.0B | $2.4B | ||
| Q3 25 | $4.2B | $2.4B | ||
| Q2 25 | $4.4B | $2.3B | ||
| Q1 25 | $4.6B | $2.2B | ||
| Q4 24 | $4.4B | $2.1B | ||
| Q3 24 | $4.2B | $2.0B | ||
| Q2 24 | $4.3B | $1.8B | ||
| Q1 24 | $4.1B | $1.7B |
| Q4 25 | $8.9B | $7.1B | ||
| Q3 25 | $9.1B | $6.9B | ||
| Q2 25 | $8.8B | $6.8B | ||
| Q1 25 | $9.0B | $6.6B | ||
| Q4 24 | $8.9B | $6.5B | ||
| Q3 24 | $8.7B | $6.5B | ||
| Q2 24 | $8.8B | $6.4B | ||
| Q1 24 | $8.6B | $6.2B |
| Q4 25 | 0.55× | 1.00× | ||
| Q3 25 | 0.52× | 1.01× | ||
| Q2 25 | 0.50× | 1.02× | ||
| Q1 25 | 0.48× | 1.08× | ||
| Q4 24 | 0.51× | 1.14× | ||
| Q3 24 | 0.53× | 1.20× | ||
| Q2 24 | 0.51× | 1.46× | ||
| Q1 24 | 0.54× | 1.54× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | — | $346.0M |
| フリーキャッシュフロー営業CF - 設備投資 | — | $116.7M |
| FCFマージンFCF / 売上 | — | 7.6% |
| 設備投資強度設備投資 / 売上 | 3.4% | 14.8% |
| キャッシュ転換率営業CF / 純利益 | — | 2.37× |
| 直近12ヶ月FCF直近4四半期 | — | $439.2M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | — | $346.0M | ||
| Q3 25 | — | $270.8M | ||
| Q2 25 | — | $270.2M | ||
| Q1 25 | — | $288.6M | ||
| Q4 24 | $292.3M | $278.8M | ||
| Q3 24 | $364.0M | $267.8M | ||
| Q2 24 | $236.9M | $217.4M | ||
| Q1 24 | $263.0M | $238.8M |
| Q4 25 | — | $116.7M | ||
| Q3 25 | — | $83.7M | ||
| Q2 25 | — | $113.3M | ||
| Q1 25 | — | $125.5M | ||
| Q4 24 | $237.7M | $80.1M | ||
| Q3 24 | $315.4M | $120.3M | ||
| Q2 24 | $206.6M | $60.5M | ||
| Q1 24 | $216.7M | $99.4M |
| Q4 25 | — | 7.6% | ||
| Q3 25 | — | 5.7% | ||
| Q2 25 | — | 7.8% | ||
| Q1 25 | — | 8.6% | ||
| Q4 24 | 15.0% | 5.7% | ||
| Q3 24 | 20.9% | 8.9% | ||
| Q2 24 | 13.7% | 4.6% | ||
| Q1 24 | 14.4% | 7.6% |
| Q4 25 | 3.4% | 14.8% | ||
| Q3 25 | 1.8% | 12.7% | ||
| Q2 25 | 1.5% | 10.8% | ||
| Q1 25 | 1.1% | 11.2% | ||
| Q4 24 | 3.5% | 14.1% | ||
| Q3 24 | 3.2% | 10.9% | ||
| Q2 24 | 2.0% | 12.1% | ||
| Q1 24 | 3.1% | 10.6% |
| Q4 25 | — | 2.37× | ||
| Q3 25 | — | 2.14× | ||
| Q2 25 | — | 1.90× | ||
| Q1 25 | — | 1.90× | ||
| Q4 24 | 1.54× | 2.31× | ||
| Q3 24 | — | 2.48× | ||
| Q2 24 | 0.97× | 1.91× | ||
| Q1 24 | 1.16× | 2.12× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
CHD
| Household Products | $645.3M | 39% |
| Personal Care Products | $625.9M | 38% |
| Consumer International | $299.8M | 18% |
| Specialty Products Division | $73.2M | 4% |
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
